2015 American Transplant Congress » Poster Session A: BK Virus Infection

Date: Saturday, May 2, 2015

Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Session Type: Poster Session

Meeting: 2015 American Transplant Congress

5:30pm-7:30pm: A Single Center Comparison of Various BK Viremia Elimination Protocols

Y. Qazi, K. Lee, B. Duong, R. Dhawan, L. Shinn, L. Aguirre, C. Parke, C. Wong, S. Alexopoulos, D. Olson, M. Smogorzewski.

5:30pm-7:30pm: Clinicopathological Scenarios (CPS) Defined by Viremia, Creatinine and Histology in Polyomavirus Nephropathy Differ in 1st and 2nd (Follow-Up) Biopsy

C. Drachenberg, M. Chaudhry, F. Yang, R. Ugarte, A. Haririan, M. Mavanur, C. Cangro, B. Thomas, N. Costa, E. Ramos, M. Weir, J. Papadimitriou.

5:30pm-7:30pm: Correlates of Clinical Course of Polyomavirus BK Infection With Long-Term Outcome of BK Virus-Associated Nephropathy in Renal Transplant Patients

G. Huang, C.-X. Wang, J.-G. Fei, J. Qiu, S.-X. Deng, J. Li, G.-D. Chen, Q. Fu, R.-H. Deng, L.-Z. Chen.

5:30pm-7:30pm: Evaluation of Leflunomide for the Treatment of BK Viremia and Biopsy Proven BK Nephropathy: A Single Center Experience

N. Nesselhauf,¹ J. Strutt,² B. Bastani.¹

5:30pm-7:30pm: Evaluation of the Gastrointestinal Tract as a Potential Route of Primary Polyomavirus Infection

G. Huang,¹ G. Zeng,² Y. Huang,² P. Randhawa.²

5:30pm-7:30pm: Evaluation of the Use of Leflunomide for the Prevention of BK Nephropathy in Renal Transplant Recipients- A Single Center Experience

S. Jonchhe, E. Hollinger, S. Jensik, O. Olaitan, A. Hodowanec, M. Hertl, S. Fayek, E. Chan, C. Pullum, N. Alvey.

5:30pm-7:30pm: Impact of Sirolimus on the Risk of BK Viremia in Simultaneous Pancreas-Kidney Transplant Recipients

D. Wojciechowski, T. Yokoyama, S. Chandran, P. Stock.

5:30pm-7:30pm: Incidence and Outcomes of Polyomavirus Infection in 639 Kidney Transplant Recipients: Are High Immunological Risk Characteristics More Relevant Than Specific Induction Or Maintenance Immunosuppressive Regimens?

E. Favi,¹ L. Harris,² J. Worsfold,² R. Cacciola,¹ C. Puliatti,¹ C. Sammartino,¹ R. Sivaprakasam.¹

5:30pm-7:30pm: Plasmapheresis – A Previously Unrecognised Risk Factor for BK Viraemia

E. Olayos,¹ K. Barraclough,² R. Walker,³ R. Masterson,² H. Peter,² C. Solomon.⁴

5:30pm-7:30pm: Prospects of Differentiating T-Cell Mediated Rejection (TCMR) from BK Virus Nephropathy (BKVN) Using Next Generation Sequencing (NGS) of the T-Cell Receptor (TCR)

G. Zeng, Y. Huang, P. Randhawa.

5:30pm-7:30pm: Renal Dysfunction by BK Virus Infection Is Correlated With Activated T Cell Level, Cytokines Level, Gramzymes in Renal Transplantation

W.-Y. Yin.

5:30pm-7:30pm: Safety and Efficacy of 3-Month Ciprofloxacin for BK Prophylaxis in Kidney Transplantation

S. Patel, R. Knight, J. Loucks, S. Kuten, A. Gaber.

5:30pm-7:30pm: Switching from Tacrolimus to Low-Dose Cyclosporine A Preserves Allograft Function in Presumptive and Definitive Polyomavirus-Associated Nephropathy

G. Huang, C.-X. Wang, J.-G. Fei, J. Qiu, S.-X. Deng, J. Li, G.-D. Chen, Q. Fu, R.-H. Deng, L.-Z. Chen.

5:30pm-7:30pm: The Role of Quantitative Assay of Urinary Decoy Cells as a Screening and Follow-Up Tool in Renal Transplant Recipients With Polyomavirus BK Infection

G. Huang, J. Qiu, C.-X. Wang, J.-G. Fei, S.-X. Deng, J. Li, G.-D. Chen, Q. Fu, R.-H. Deng, L.-Z. Chen.

« View all sessions from the 2015 American Transplant Congress